Eidos Therapeutics Inc (EIDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | EIDX | AXSM | ALKS | ||
| Company | Eidos Therapeutics Inc | Axsome Thera | Alkermes Plc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 127.57 | 98.99 | 27.86 | ||
| High | 128.49 | 99.30 | 29.13 | ||
| Low | 116.83 | 96.79 | 27.58 | ||
| Last | 122.21 | 98.68 | 28.78 | ||
| Change | -6.23 | +0.49 | +1.08 | ||
| % Change | -4.85% | +0.50% | +3.90% | ||
| Volume | 335,500 | 427,200 | 2,150,800 | ||
| 20-Day Average Volume | 113,985 | 568,440 | 1,654,925 | ||
| Previous Close | 128.44 | 98.19 | 27.70 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 124.59 | 92.71 | 27.90 | ||
| 20-Day Raw Stochastic | 36.63% | 66.63% | 67.17% | ||
| 20-Day Relative Strength | 56.42% | 60.07% | 54.32% | ||
| Weighted Alpha | +136.62 | +55.50 | +17.94 | ||
| Today's Opinion | 88% Buy | 100% Buy | 100% Buy | ||
| Previous Opinion | 100% Buy | 100% Buy | 56% Buy | ||
| Last Month's Opinion | 100% Buy | 48% Buy | 48% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.40% since 01/15/21 | +5.91% since 11/15/24 | +2.09% since 11/15/24 | ||
| Low | 116.83 on 01/25/21 | 90.86 on 11/19/24 | 27.11 on 11/19/24 | ||
| High | 131.08 on 01/20/21 | 99.35 on 11/21/24 | 29.13 on 11/22/24 | ||
| 1-Month | |||||
| %Chg | -4.30% since 12/24/20 | +6.80% since 10/22/24 | +2.42% since 10/22/24 | ||
| Low | 116.24 on 01/05/21 | 86.06 on 11/05/24 | 25.67 on 10/31/24 | ||
| High | 132.54 on 01/04/21 | 105.00 on 11/13/24 | 30.30 on 11/12/24 | ||
| 3-Month | |||||
| %Chg | +66.75% since 10/23/20 | +13.28% since 08/22/24 | +2.82% since 08/22/24 | ||
| Low | 69.38 on 10/30/20 | 80.85 on 10/10/24 | 25.65 on 09/10/24 | ||
| High | 132.54 on 01/04/21 | 105.00 on 11/13/24 | 30.30 on 11/12/24 | ||
| 6-Month | |||||
| %Chg | +178.07% since 07/24/20 | +28.51% since 05/22/24 | +18.88% since 05/22/24 | ||
| Low | 38.44 on 07/31/20 | 64.11 on 06/11/24 | 22.90 on 07/10/24 | ||
| High | 132.54 on 01/04/21 | 105.00 on 11/13/24 | 30.30 on 11/12/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 4,750,670 | 4,782,231 | 4,656,691 | ||
| Shares Outstanding, K | 38,873 | 48,462 | 161,803 | ||
| Annual Sales | 26,690,000 | 270,600,000 | 1,663,410,000 | ||
| Annual Net Income | -37,840,000 | -239,240,000 | 355,760,000 | ||
| Last Quarter Sales | 130,000 | 104,760,000 | 378,140,000 | ||
| Last Quarter Net Income | -30,180,000 | -64,600,000 | 92,380,000 | ||
| 60-Month Beta | -0.16 | 1.26 | 0.47 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -1.34 on 11/12/24 | 0.73 on 10/24/24 | ||
| Latest Earnings Date | 02/24/21 | 11/12/24 | 10/24/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 15.05 | ||